Canada markets closed

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
8.11+0.46 (+6.01%)
At close: 04:00PM EDT
8.41 +0.30 (+3.70%)
After hours: 05:43PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.59M
Enterprise Value 4.72M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.80
Price/Book (mrq)6.81
Enterprise Value/Revenue 2.93
Enterprise Value/EBITDA -0.46

Trading Information

Stock Price History

Beta (5Y Monthly) 1.76
52-Week Change 3-45.13%
S&P500 52-Week Change 323.57%
52 Week High 327.90
52 Week Low 35.00
50-Day Moving Average 314.38
200-Day Moving Average 39.69

Share Statistics

Avg Vol (3 month) 319.99k
Avg Vol (10 day) 333.57k
Shares Outstanding 51.07M
Implied Shares Outstanding 61.16M
Float 849.85M
% Held by Insiders 10.00%
% Held by Institutions 118.33%
Shares Short (Apr 15, 2024) 421.71k
Short Ratio (Apr 15, 2024) 41.18
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 42.03%
Shares Short (prior month Mar 15, 2024) 411.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Oct 23, 2023

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,459.20%

Management Effectiveness

Return on Assets (ttm)-99.44%
Return on Equity (ttm)-348.48%

Income Statement

Revenue (ttm)1.65M
Revenue Per Share (ttm)2.64
Quarterly Revenue Growth (yoy)-69.30%
Gross Profit (ttm)N/A
EBITDA -10.26M
Net Income Avi to Common (ttm)-10.56M
Diluted EPS (ttm)-18.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.87M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)344.34k
Total Debt/Equity (mrq)30.06%
Current Ratio (mrq)1.46
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-7.99M
Levered Free Cash Flow (ttm)-4.22M